Hilltop Partners’s Eli Lilly LLY Stock Holding History

Hilltop Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.42M	Buy	5,891 +384	+7%	+$389K	1.39%	17
2025 Q4	$5.92M	Buy	5,507 +1,559	+39%	+$1.49M	1.53%	16
2025 Q3	$3.01M	Buy	3,948 +1,618	+69%	+$1.2M	0.9%	28
2025 Q2	$1.82M	Buy	2,330 +597	+34%	+$464K	0.55%	33
2025 Q1	$1.43M	Sell	1,733 -10	-0.6%	-$8.32K	0.48%	36
2024 Q4	$1.35M	Buy	1,743 +497	+40%	+$412K	0.46%	35
2024 Q3	$1.1M	Buy	1,246 +63	+5%	+$56.6K	0.37%	37
2024 Q2	$1.07M	Buy	1,183 +208	+21%	+$166K	0.4%	38
2024 Q1	$758K	Buy	975 +71	+8%	+$50.5K	0.27%	56
2023 Q4	$527K	Buy	904 +418	+86%	+$244K	0.21%	60
2023 Q3	$261K	Buy	486 +15	+3%	+$7.73K	0.11%	83
2023 Q2	$221K	Buy	+471	New	+$198K	0.09%	90

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hilltop Partners's LLY Position: Q1 2026 in Review

Hilltop Partners increased its Eli Lilly (LLY) stake by 7% in Q1 2026, buying an estimated $389K and bringing the position to 5,891 shares worth $5.42M. The position accounts for 1.39% of the portfolio, ranked #17.

Hilltop Partners first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.92M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Hilltop Partners held 5,891 shares of Eli Lilly worth $5.42M as of Q1 2026.
Hilltop Partners bought 384 Eli Lilly shares in Q1 2026, an estimated $389K.
Eli Lilly made up 1.39% of Hilltop Partners's portfolio in Q1 2026, its #17 holding.
Hilltop Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
Hilltop Partners's Eli Lilly position peaked at $5.92M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hilltop Partners's 13F filing for Q1 2026, filed 12 May 2026.